Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001829126-25-007999
Filing Date
2025-10-09
Accepted
2025-10-09 17:21:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM titanpharma_posam.htm POS AM 32394
  Complete submission text file 0001829126-25-007999.txt   33456
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-221126 | Film No.: 251385883
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)